These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 39216826)

  • 41. Radiotherapy for solitary extramedullary plasmacytoma in the head-and-neck region: A dose greater than 45 Gy to the target volume improves the local control.
    Tournier-Rangeard L; Lapeyre M; Graff-Caillaud P; Mege A; Dolivet G; Toussaint B; Charra-Brunaud C; Hoffstetter S; Marchal C; Peiffert D
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1013-7. PubMed ID: 16343803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pancreatic cancer adjuvant radiotherapy target volume design: based on the postoperative local recurrence spatial location.
    Yu W; Hu W; Shui Y; Zhu X; Li C; Ren X; Bai X; Yu R; Shen L; Liang T; Zheng L; Wei Q
    Radiat Oncol; 2016 Oct; 11(1):138. PubMed ID: 27756417
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes of definitive carbon-ion radiotherapy for cT1bN0M0 esophageal squamous cell carcinoma.
    Isozaki T; Ishikawa H; Yamada S; Nabeya Y; Minashi K; Murakami K; Matsubara H
    Esophagus; 2024 Oct; 21(4):523-529. PubMed ID: 38814482
    [TBL] [Abstract][Full Text] [Related]  

  • 44.
    Nakaji T; Shinoto M; Yamada S; Inaniwa T
    Anticancer Res; 2024 Sep; 44(9):3821-3828. PubMed ID: 39197905
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of the dose-volume relationship on and risk factors for maxillary osteoradionecrosis after carbon ion radiotherapy.
    Sasahara G; Koto M; Ikawa H; Hasegawa A; Takagi R; Okamoto Y; Kamada T
    Radiat Oncol; 2014 Apr; 9(1):92. PubMed ID: 24708583
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Feasibility of Selective Neck Irradiation with Lower Elective Radiation Dose in Treating Nasopharynx Cancer Patients.
    Cho WK; Oh D; Lee E; Kim TG; Lee H; Nam H; Noh JM; Ahn YC
    Cancer Res Treat; 2019 Apr; 51(2):603-610. PubMed ID: 30025444
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-dose proton beam therapy for sinonasal mucosal malignant melanoma.
    Fuji H; Yoshikawa S; Kasami M; Murayama S; Onitsuka T; Kashiwagi H; Kiyohara Y
    Radiat Oncol; 2014 Jul; 9():162. PubMed ID: 25056641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M. D. Anderson Cancer Center.
    Moreno MA; Roberts DB; Kupferman ME; DeMonte F; El-Naggar AK; Williams M; Rosenthal DS; Hanna EY
    Cancer; 2010 May; 116(9):2215-23. PubMed ID: 20198705
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-dose carbon-ion based radiotherapy of primary and recurrent sacrococcygeal chordomas: long-term clinical results of a single particle therapy center.
    Bostel T; Mattke M; Nicolay NH; Welzel T; Wollschläger D; Akbaba S; Mayer A; Sprave T; Debus J; Uhl M
    Radiat Oncol; 2020 Aug; 15(1):206. PubMed ID: 32831113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single fraction carbon ion radiotherapy for colorectal cancer liver metastasis: A dose escalation study.
    Makishima H; Yasuda S; Isozaki Y; Kasuya G; Okada N; Miyazaki M; Mohamad O; Matsufuji N; Yamada S; Tsuji H; Kamada T;
    Cancer Sci; 2019 Jan; 110(1):303-309. PubMed ID: 30417485
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sino-nasal mucosal malignant melanoma.
    Karim MU; Khan K; Ali N; Ikram M
    BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25926579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Probabilistic dose distribution from interfractional motion in carbon ion radiation therapy for prostate cancer shows rectum sparing with moderate target coverage degradation.
    Bridges D; Kawamura H; Kanai T
    PLoS One; 2018; 13(8):e0203289. PubMed ID: 30169520
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carbon ion reirradiation compared to intensity-modulated re-radiotherapy for recurrent head and neck cancer (CARE): a randomized controlled trial.
    Held T; Lang K; Regnery S; Weusthof K; Hommertgen A; Jäkel C; Tonndorf-Martini E; Krisam J; Plinkert P; Zaoui K; Freudlsperger C; Moratin J; Krauss J; Harrabi SB; Herfarth K; Debus J; Adeberg S
    Radiat Oncol; 2020 Aug; 15(1):190. PubMed ID: 32758267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carbon-ion radiotherapy for locally advanced primary or postoperative recurrent epithelial carcinoma of the lacrimal gland.
    Mizoguchi N; Tsuji H; Toyama S; Kamada T; Tsujii H; Nakayama Y; Mizota A; Ohnishi Y;
    Radiother Oncol; 2015 Mar; 114(3):373-7. PubMed ID: 25687727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Head and neck mucosal melanoma.
    Mendenhall WM; Amdur RJ; Hinerman RW; Werning JW; Villaret DB; Mendenhall NP
    Am J Clin Oncol; 2005 Dec; 28(6):626-30. PubMed ID: 16317276
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intensity-modulated radiotherapy for sinonasal tumors: Ghent University Hospital update.
    Madani I; Bonte K; Vakaet L; Boterberg T; De Neve W
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):424-32. PubMed ID: 18755554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictive value of 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography/computed tomography for outcome of carbon ion radiotherapy in patients with head and neck mucosal malignant melanoma.
    Inubushi M; Saga T; Koizumi M; Takagi R; Hasegawa A; Koto M; Wakatuki M; Morikawa T; Yoshikawa K; Tanimoto K; Fukumura T; Yamada S; Kamada T
    Ann Nucl Med; 2013 Jan; 27(1):1-10. PubMed ID: 22914968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical research of the value of high-risk CTV setting on intensity-modulated radiotherapy for stage IIB-IVA cervical cancer.
    Jiang Y; Wang J; Jiang P; Wang X; Zhang L; Zhang Y
    BMC Cancer; 2023 May; 23(1):481. PubMed ID: 37245053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radiotherapy Characteristics and Outcomes for Head and Neck Carcinoma of Unknown Primary vs T1 Base-of-Tongue Carcinoma.
    Hosni A; Dixon PR; Rishi A; Au M; Xu W; Song Y; Chepeha DB; Goldstein DP; Huang SH; Kim J; O'Sullivan B; Waldron J; Bratman SV; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1208-1215. PubMed ID: 27812692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential of intensity-modulated radiotherapy to escalate doses to head-and-neck cancers: what is the maximal dose?
    Zhou J; Fei D; Wu Q
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):673-82. PubMed ID: 14529771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.